Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
203M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
33.8M
-
Shares change
-
-4.78M
-
Total reported value, excl. options
-
$293M
-
Value change
-
-$50M
-
Put/Call ratio
-
0.09
-
Number of buys
-
64
-
Number of sells
-
-57
-
Price
-
$8.69
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2021
157 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.8M shares
of 203M outstanding shares and own 16.66% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (4.95M shares), STATE STREET CORP (4.11M shares), VANGUARD GROUP INC (3.75M shares), BlackRock Inc. (3.25M shares), Alpine Global Management, LLC (3M shares), TWO SIGMA INVESTMENTS, LP (1.14M shares), EcoR1 Capital, LLC (1.14M shares), TWO SIGMA ADVISERS, LP (1.01M shares), MORGAN STANLEY (865K shares), and GEODE CAPITAL MANAGEMENT, LLC (856K shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.